This document presents evidence that higher serum 25(OH)D levels are associated with reduced risk of various diseases. It shows that levels above 30 ng/mL are linked to substantially lower rates of breast cancer, colorectal cancer, non-Hodgkin's lymphoma, multiple sclerosis, and falls in women. Levels between 40-60 ng/mL may be needed to prevent most chronic diseases, as this range is associated with significantly reduced incidence of cancer, cardiovascular disease, diabetes, and autoimmune conditions. Reference data is provided on average 25(OH)D levels in different populations, with tribal East Africans having the highest at 115 nmol/L.